visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Acorda Therapeutics, Inc.

    Get Full Access

    Description

    • Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); Selincro for the treatment of alcohol dependence; and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also markets Ampyra as Fampyra in Europe, Asia, and the Americas. In addition, the company develops ARCUS product for the treatment of acute migrain; rHIgM22, which has completed Phase I clinical trial for the treatment of MS; and Cimaglermin alfa for heart failure patients. The company has collaboration and license agreement with Biogen Inc. for the development and commercialization of Ampyra. Acorda Therapeutics, Inc. was incorporated in 1995 and is headquartered in Ardsley, New York.
    • location

      Headquarters:420 Saw Mill , Ardsley, New York, United States

      More
    • Acorda Therapeutics, Inc. phone

      Phone Number: +1 914-347-4300

    • Acorda Therapeutics, Inc. website

      Website: https://www.acorda.com

    • Acorda Therapeutics, Inc. employees

      Employees:447

    • Acorda Therapeutics, Inc. revenue

      Revenue:$100 - 250M

    • Acorda Therapeutics, Inc. legal name

      Legal Name:Acorda Therapeutics, Inc.

    • Acorda Therapeutics, Inc.'s Social Media

      Acorda Therapeutics, Inc. linkedin
    • done Is this data correct?

    • |  NAICS Code: 325412  |

        NYSE: ACOR

      Show More
    Person level website identification

    Chief Operating Officer for Acorda Therapeutics, Inc.

    Lauren Sabella

    Chief Operating Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Lauren Sabella

    Chief Operating Officer

    Kerry Clem

    Chief Commercial Officer

    Asra Warsi

    Vice President Clinical Operations

    Pasqual Zottola

    Vice President - Information Technology

    Michael Russo

    Vice President- Digital Strategy And Innovation

    Frequently Asked Questions regarding Acorda Therapeutics, Inc.

    • Where are Acorda Therapeutics, Inc.'s Headquarters?

      Acorda Therapeutics, Inc.'s Headquarters are in 420 Saw Mill ,Ardsley,New York,United States

    • What is Acorda Therapeutics, Inc.'s phone number?

      Acorda Therapeutics, Inc.'s phone number is +1 914-347-4300

    • What is Acorda Therapeutics, Inc.'s stock symbol?

      Acorda Therapeutics, Inc.'s stock symbol is ACOR

    • What is Acorda Therapeutics, Inc.'s official website?

      Acorda Therapeutics, Inc.'s official website is https://www.acorda.com

    • What is Acorda Therapeutics, Inc.'s Revenue?

      Acorda Therapeutics, Inc.'s revenue is $100 - 250M

    • What is Acorda Therapeutics, Inc.'s NAICS code?

      Acorda Therapeutics, Inc.'s NAICS code is 325412

    • How many employees are working in Acorda Therapeutics, Inc.

      Acorda Therapeutics, Inc. has 447 employees

    • What is Acorda Therapeutics, Inc.'s Industry?

      Acorda Therapeutics, Inc. is in the industry of Biotechnology

    Company Directory